Arrowhead Pharmaceuticals, Inc. (ARWR) Presents At H.C. Wainwright 27th Annual Global Investment Conference Transcript

Question-and-Answer SessionSo just to begin, if we could, start with an overview of the -- of Arrowhead today, the scope of the pipeline, therapeutic areas you're prioritizing and strategic pillars guiding execution.Dr. Christopher AnzaloneChairman, CEO & President Sure. Thanks very much, and thanks for having us. It's really a pleasure to be here. We are a broad-based RNAi company. We have leveraged this modality to get into a number of different cell types. And therefore, we have the ability to treat a nu ...